BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang X, Francisconi CF, Fukudo S, Gerson MJ, Kang JY, Schmulson W MJ, Sperber AD. Multicultural Aspects in Functional Gastrointestinal Disorders (FGIDs). Gastroenterology 2016:S0016-5085(16)00179-7. [PMID: 27144623 DOI: 10.1053/j.gastro.2016.02.013] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 6.3] [Reference Citation Analysis]
Number Citing Articles
1 Rahal HK, Tabibian JH, Issaka RB, Quezada S, Gray DM 2nd, Balzora S, Yang L, Badiee J, May FP. Diversity, equity, and inclusion in gastroenterology and hepatology: a survey of where we stand. Gastrointest Endosc 2022;96:887-97. [PMID: 36241459 DOI: 10.1016/j.gie.2022.08.029] [Reference Citation Analysis]
2 Rahal HK, Tabibian JH, Issaka RB, Quezada S, Gray DM 2nd, Balzora S, Yang L, Badiee J, May FP. Diversity, equity, and inclusion in gastroenterology and hepatology: A survey of where we stand. Hepatology 2022;76:1825-35. [PMID: 36219467 DOI: 10.1002/hep.32757] [Reference Citation Analysis]
3 Rahal HK, Tabibian JH, Issaka RB, Quezada S, Gray DM 2nd, Balzora S, Yang L, Badiee J, May FP. Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand. Gastroenterology 2022;163:1702-11. [PMID: 36241487 DOI: 10.1053/j.gastro.2022.06.059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rahal HK, Tabibian JH, Issaka R, Quezada S, Gray D 2nd, Balzora S, Yang L, Badiee J, May F. Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand. Am J Gastroenterol 2022;117:1954-62. [PMID: 36040427 DOI: 10.14309/ajg.0000000000001984] [Reference Citation Analysis]
5 Rahal H, Girotra M, May FP, Tabibian JH. Gender, Race, and Ethnicity Representation Among Gastroenterologists: A Review of Recent Trends. Am J Gastroenterol 2022;117:1566-72. [PMID: 36194046 DOI: 10.14309/ajg.0000000000001880] [Reference Citation Analysis]
6 Fang XC, Fan WJ, Drossman DD, Han SM, Ke MY. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain? World J Gastroenterol 2022; 28(33): 4861-4874 [DOI: 10.3748/wjg.v28.i33.4861] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Velasco-Benítez CA, Collazos-Saa LI, García-Perdomo HA. Functional Gastrointestinal Disorders in Neonates and Toddlers According to the Rome IV Criteria: A Systematic Review and Meta-Analysis. Pediatr Gastroenterol Hepatol Nutr 2022;25:376-86. [PMID: 36148289 DOI: 10.5223/pghn.2022.25.5.376] [Reference Citation Analysis]
8 Rábago R, Bonilla A, Escamilla-Diego E, Higuera de la Tijera MF, Schmulson M. Pictograms are more effective than verbal descriptors in Spanish for bloating and distension. Neurogastroenterol Motil 2022;34:e14364. [PMID: 35394646 DOI: 10.1111/nmo.14364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sebaratnam G, Karulkar N, Calder S, Woodhead JST, Keane C, Carson DA, Varghese C, Du P, Waite SJ, Tack J, Andrews CN, Broadbent E, Gharibans AA, O'Grady G. Standardized system and App for continuous patient symptom logging in gastroduodenal disorders: Design, implementation, and validation. Neurogastroenterol Motil 2022;34:e14331. [PMID: 35156270 DOI: 10.1111/nmo.14331] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
10 Batista ADO, Dantas RO. CORRELATION BETWEEN SYMPTOMS AND REFLUX IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE. Arq Gastroenterol 2022;59:184-187. [DOI: 10.1590/s0004-2803.202202000-34] [Reference Citation Analysis]
11 Sebaratnam G, Karulkar N, Calder S, Woodhead J, Keane C, Carson D, Varghese C, Du P, Waite S, Tack J, Andrews C, Broadbent E, Gharibans A, O’grady G. A standardized system and App for continuous patient symptom logging in gastroduodenal disorders: design, implementation, and validation.. [DOI: 10.1101/2021.09.06.21263001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
12 Norwood DA, Dominguez LB, Paredes AA, Montalvan EE, Rodriguez Murillo A, Dougherty MK, Palsson OS, Dominguez RL, Morgan DR. Prevalence and Associated Dietary Factors of Rome IV Functional Gastrointestinal Disorders in Rural Western Honduras. Dig Dis Sci 2021;66:3086-95. [PMID: 33089482 DOI: 10.1007/s10620-020-06639-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Qiao R, Zhou L, Zhong M, Zhang M, Yang L, Yang Y, Chen H, Yang W, Yuan J. Spectrum-effect relationship between UHPLC-Q-TOF/MS fingerprint and promoting gastrointestinal motility activity of Fructus aurantii based on multivariate statistical analysis. J Ethnopharmacol 2021;279:114366. [PMID: 34181960 DOI: 10.1016/j.jep.2021.114366] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
14 Roberts CM, Chaney JM. JPP Student Journal Club Commentary: Family Functioning in Pediatric Functional Gastrointestinal Disorders. J Pediatr Psychol 2021;46:501-3. [PMID: 34041551 DOI: 10.1093/jpepsy/jsab051] [Reference Citation Analysis]
15 Milosavljevic T, Popovic DD, Mijac DD, Milovanovic T, Krstic S, Krstic MN. Chronic Constipation: Gastroenterohepatologist's Approach. Dig Dis 2022;40:175-80. [PMID: 33946065 DOI: 10.1159/000516976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
16 Garr K, Odar Stough C, Origlio J. Family Functioning in Pediatric Functional Gastrointestinal Disorders: A Systematic Review. J Pediatr Psychol 2021:jsab007. [PMID: 33876231 DOI: 10.1093/jpepsy/jsab007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Suriani R, Ercole E, Niola P, Astegiano M, Sambataro A, Ravizza M. IBD passport: A novel educational model in IBD patients. Dig Liver Dis 2020;52:1067-8. [PMID: 32522432 DOI: 10.1016/j.dld.2020.05.012] [Reference Citation Analysis]
18 Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol 2020;17:473-86. [PMID: 32296140 DOI: 10.1038/s41575-020-0286-8] [Cited by in Crossref: 127] [Cited by in F6Publishing: 104] [Article Influence: 42.3] [Reference Citation Analysis]
19 Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:908-917. [PMID: 32702295 DOI: 10.1016/s2468-1253(20)30217-x] [Cited by in Crossref: 155] [Cited by in F6Publishing: 166] [Article Influence: 51.7] [Reference Citation Analysis]
20 Xiao QY, Fang XC, Li XQ, Fei GJ. Ethnic differences in genetic polymorphism associated with irritable bowel syndrome. World J Gastroenterol 2020; 26(17): 2049-2063 [PMID: 32536774 DOI: 10.3748/wjg.v26.i17.2049] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
21 Hale AE, Smith AM, Christiana JS, Burch E, Schechter NL, Beinvogl BC, Paul F, Henaghan AS, Logan D, Nurko S. Perceptions of Pain Treatment in Pediatric Patients With Functional Gastrointestinal Disorders. The Clinical Journal of Pain 2020;36:550-7. [DOI: 10.1097/ajp.0000000000000832] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Costa TV, Dantas RO. ALTERED ESOPHAGEAL MOTILITY DURING PERCEPTION OF BOLUS TRANSIT IN HEALTHY VOLUNTEERS. Arq Gastroenterol 2019;56:386-9. [PMID: 31800734 DOI: 10.1590/S0004-2803.201900000-78] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Carethers JM, Quezada SM, Carr RM, Day LW. Diversity Within US Gastroenterology Physician Practices: The Pipeline, Cultural Competencies, and Gastroenterology Societies Approaches. Gastroenterology 2019;156:829-33. [PMID: 30452917 DOI: 10.1053/j.gastro.2018.10.056] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
24 Atkinson NSS. Constipation. Inflammatory Bowel Disease Nursing Manual 2019. [DOI: 10.1007/978-3-319-75022-4_33] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Fukudo S, Miwa H, Nakajima A, Kinoshita Y, Kosako M, Hayashi K, Akiho H, Kuroishi K, Johnston JM, Currie M, Ohkusa T. High-dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double-blind, placebo-controlled study with a long-term open-label extension study in Japan. Neurogastroenterol Motil 2019;31:e13487. [PMID: 30353619 DOI: 10.1111/nmo.13487] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
26 Kosako M, Akiho H, Miwa H, Kanazawa M, Fukudo S. Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey. Biopsychosoc Med 2018;12:18. [PMID: 30534195 DOI: 10.1186/s13030-018-0137-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
27 Fukudo S, Miwa H, Nakajima A, Haruma K, Kosako M, Nakagawa A, Akiho H, Yamaguchi Y, Johnston JM, Currie M, Kinoshita Y. A randomized controlled and long-term linaclotide study of irritable bowel syndrome with constipation patients in Japan. Neurogastroenterol Motil 2018;30:e13444. [PMID: 30136447 DOI: 10.1111/nmo.13444] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
28 Fukudo S, Miwa H, Nakajima A, Kinoshita Y, Kosako M, Nakagawa A, Akiho H, Kuroishi K, Johnston JM, Currie M, Ohkusa T. Dose-finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double-blind, and placebo-controlled study. Neurogastroenterol Motil 2018;30:e13442. [PMID: 30084233 DOI: 10.1111/nmo.13442] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
29 Skonieczna-Żydecka K, Stachowska E, Maciejewska D, Ryterska K, Palma J, Czerwińska-Rogowska M, Kaczmarczyk M, Gudan A, Mruk H, Świniarska B, Kałduńska J, Stachowska Z, Mijal P, Mazur T, Kupczyński M, Marlicz W. The Digestive Health among Participants of the Woodstock Rock Festival in Poland-A Cross-Sectional Survey. Int J Environ Res Public Health 2018;15:E2256. [PMID: 30326654 DOI: 10.3390/ijerph15102256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
30 Chuah KH, Mahadeva S. Cultural Factors Influencing Functional Gastrointestinal Disorders in the East. J Neurogastroenterol Motil 2018;24:536-43. [PMID: 30153722 DOI: 10.5056/jnm18064] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
31 Zuckerman MJ, Schmulson MJ, Bashashati M, Jia Y, Dwivedi A, Ortiz M, Casner N, Byrd T, Shokar N. Irritable Bowel Syndrome on the US Mexico Border: A Survey in an Indigent Population Using Rome III Criteria. J Clin Gastroenterol 2018;52:622-7. [PMID: 28787361 DOI: 10.1097/MCG.0000000000000898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Fukudo S, Nakajima A, Fujiyama Y, Kosako M, Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H. Randomized, double-blind, placebo-controlled study vs data in the daily practice using linaclotide in patients with irritable bowel syndrome with constipation. Neurogastroenterol Motil 2018;30:e13363. [PMID: 29700962 DOI: 10.1111/nmo.13363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Dantas RO, Oliveira L. Influence of the syringe model on the results of the International Dysphagia Diet Standardisation initiative flow test. Rev CEFAC 2018;20:382-7. [DOI: 10.1590/1982-021620182031818] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
34 Fukudo S, Nakajima A, Fujiyama Y, Kosako M, Nakagawa A, Akiho H, Nakashima Y, Johnston JM, Miwa H. Determining an optimal dose of linaclotide for use in Japanese patients with irritable bowel syndrome with constipation: A phase II randomized, double-blind, placebo-controlled study. Neurogastroenterol Motil 2018;30:e13275. [PMID: 29278278 DOI: 10.1111/nmo.13275] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
35 Jang SH, Kim YS. Could Improvement in Subjective Well-being Relieve Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome? J Neurogastroenterol Motil 2018;24:164-5. [PMID: 29605973 DOI: 10.5056/jnm18053] [Reference Citation Analysis]
36 Chogle A, Velasco-Benitez CA, Chanis R, Mejia M, Saps M. Multicountry cross-sectional study found that functional gastrointestinal disorders such as colic and functional dyschezia were common in South American infants. Acta Paediatr 2018;107:708-13. [PMID: 29266391 DOI: 10.1111/apa.14196] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
37 Alves DC, Dantas RO. Difficulties in thickened water ingestion in healthy subjects. Clin Nutr ESPEN 2017;22:107-11. [PMID: 29415826 DOI: 10.1016/j.clnesp.2017.07.077] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
38 Chu NHS, Yao CK, Tan VPY. Food Therapy in Sinosphere Asia. J Clin Gastroenterol 2018;52:105-13. [PMID: 28961572 DOI: 10.1097/MCG.0000000000000932] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
39 Gwee KA, Ghoshal UC, Chen M. Irritable bowel syndrome in Asia: Pathogenesis, natural history, epidemiology, and management. J Gastroenterol Hepatol 2018;33:99-110. [PMID: 28901578 DOI: 10.1111/jgh.13987] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 9.2] [Reference Citation Analysis]
40 Ghoshal UC, Shukla R, Ghoshal U. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy. Gut Liver. 2017;11:196-208. [PMID: 28274108 DOI: 10.5009/gnl16126] [Cited by in Crossref: 91] [Cited by in F6Publishing: 95] [Article Influence: 15.2] [Reference Citation Analysis]
41 Lee C, Doo E, Choi JM, Jang SH, Ryu HS, Lee JY, Oh JH, Park JH, Kim YS; Brain-Gut Axis Research Group of Korean Society of Neurogastroenterology and Motility. The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis. J Neurogastroenterol Motil 2017;23:349-62. [PMID: 28672433 DOI: 10.5056/jnm16220] [Cited by in Crossref: 105] [Cited by in F6Publishing: 117] [Article Influence: 17.5] [Reference Citation Analysis]
42 Schmulson MJ, Drossman DA. What Is New in Rome IV. J Neurogastroenterol Motil. 2017;23:151-163. [PMID: 28274109 DOI: 10.5056/jnm16214] [Cited by in Crossref: 313] [Cited by in F6Publishing: 336] [Article Influence: 52.2] [Reference Citation Analysis]
43 Drossman DA, Hasler WL. Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology 2016;150:1257-61. [PMID: 27147121 DOI: 10.1053/j.gastro.2016.03.035] [Cited by in Crossref: 731] [Cited by in F6Publishing: 748] [Article Influence: 104.4] [Reference Citation Analysis]